RxSight, Inc. (RXST) Return on equity 2021–2025
RxSight, Inc. (RXST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
0.0%FY2025 · since FY2021: -35.2% → 0.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 0.0% | -0.0 pp |
| FY2024 | 0.0% | +0.0 pp |
| FY2023 | 0.0% | +0.0 pp |
| FY2022 | 0.0% | +35.2 pp |
| FY2021 | -35.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice